242 related articles for article (PubMed ID: 35464470)
1. The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis.
Perrin S; Magill M
Front Immunol; 2022; 13():861471. PubMed ID: 35464470
[TBL] [Abstract][Full Text] [Related]
2. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
3. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
[TBL] [Abstract][Full Text] [Related]
4. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
5. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
6. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
7. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
[TBL] [Abstract][Full Text] [Related]
8. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions.
Wang CY; Mazer SP; Minamoto K; Takuma S; Homma S; Yellin M; Chess L; Fard A; Kalled SL; Oz MC; Pinsky DJ
Circulation; 2002 Apr; 105(13):1609-14. PubMed ID: 11927531
[TBL] [Abstract][Full Text] [Related]
9. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.
Lassiter G; Otsuka R; Hirose T; Rosales I; Karadagi A; Tomosugi T; Dehnadi A; Lee H; Colvin RB; Baardsnes J; Moraitis A; Smith EE; Ali Z; Berhe P; Mulder A; Meibohm B; Daugherty B; Fogarty S; Pierson RN; Lederman S; Kawai T
Am J Transplant; 2023 Aug; 23(8):1171-1181. PubMed ID: 37019335
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40-CD154 costimulatory pathway promotes long-term survival of full-thickness porcine corneal grafts in nonhuman primates: clinically applicable xenocorneal transplantation.
Choi HJ; Lee JJ; Kim DH; Kim MK; Lee HJ; Ko AY; Kang HJ; Park C; Wee WR
Am J Transplant; 2015 Mar; 15(3):628-41. PubMed ID: 25676390
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
[TBL] [Abstract][Full Text] [Related]
12. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
13. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants.
Qian Y; Dana MR
Cornea; 2002 Aug; 21(6):592-7. PubMed ID: 12131037
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
15. CD11b is a novel alternate receptor for CD154 during alloimmunity.
Liu D; Ford ML
Am J Transplant; 2020 Aug; 20(8):2216-2225. PubMed ID: 32149455
[TBL] [Abstract][Full Text] [Related]
16. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.
Miura S; Habibabady ZA; Pollok F; Ma M; Rosales IA; Kinoshita K; Pratts S; McGrath G; Chaban R; Fogarty S; Meibohm B; Daugherty B; Lederman S; Pierson RN
Am J Transplant; 2023 Aug; 23(8):1182-1193. PubMed ID: 37030662
[TBL] [Abstract][Full Text] [Related]
17. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation.
Singh AK; Goerlich CE; Zhang T; Lewis BGT; Hershfeld A; Mohiuddin MM
Transplantation; 2023 Jul; 107(7):1472-1481. PubMed ID: 36584382
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
19. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
